Optimization and biological evaluation of aminopyrimidine-based I kappa B kinase beta inhibitors with potent anti-inflammatory effects

Targeting I kappa B kinase beta (IKK beta) can be a promising strategy in the development of a therapeutic treatment of inflammatory diseases because IKK beta is well-recognized as a key mediator of the NF-kappa B signaling pathway. In this study, we have successfully developed a structure-activity relationship (SAR) profile of the aminopyrimidine-based IKK beta inhibitors through the structure-based design strategy to improve the physicochemical properties and cellular activity in terms of the anti-inflammatory effects. Representative compounds exhibited desirable activity in nitric oxide (NO) reduction by inhibiting the synthesis of inducible nitric oxide synthase (iNOS), and strongly inhibited the expression of pro-inflammatory cytokines (IL-1 alpha, IL-6, and TNF-alpha). The inhibitory effects of 8e on the phosphorylation in the NF-kappa B pathway further supported that the suppression of the NF-kappa B signaling pathway induced the anti-inflammatory effect in LPS-stimulated Raw 264.7 cells. (C) 2016 Elsevier Masson SAS. All rights reserved
Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Issue Date
2016-11
Language
ENG
Citation

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.123, pp.544 - 556

ISSN
0223-5234
DOI
10.1016/j.ejmech.2016.07.075
URI
http://hdl.handle.net/10203/214413
Appears in Collection
CH-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
  • Hit : 76
  • Download : 0
  • Cited 0 times in thomson ci
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡClick to seewebofscience_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0